Basal CD34+ Cell Count Predicts Peripheral Blood Stem Cell Mobilization in Healthy Donors after Administration of Granulocyte Colony–Stimulating Factor: A Longitudinal, Prospective, Observational, Single-Center, Cohort Study

Biology of Blood and Marrow Transplantation

Volumn 23, Issue 7, 2017, Pages 1215-1220

  Martino, Massimo ^a   Gori, Mercedes ^b   Pitino, Annalisa ^b   Gentile, Massimo ^c   Dattola, Antonia ^a   Pontari, Antonella ^a   Vigna, Ernesto ^c   Moscato, Tiziana ^a   Recchia, Anna Grazia ^d   Barilla, Santina ^a   Tripepi, Giovanni ^b   Morabito, Fortunato ^c,d  

^a Cardiology Department   (Italy)

^b CNR   (Italy)

^c Ospedale Annunziata   (Italy)

^d Biotechnology Research Unit   (Italy)

Author keywords

CD34+; Granulocyte colony stimulating factor; Healthy donors; Stem cell mobilization; Stem cell transplantation

Indexed keywords

HEMOGLOBIN; LENOGRASTIM; PARACETAMOL; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGE; ARTICLE; BLOOD VOLUME; BODY HEIGHT; BODY WEIGHT; CD34 CELL COUNT; CELL COUNT; COHORT ANALYSIS; FEMALE; GENDER; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; LONGITUDINAL STUDY; MALE; MONONUCLEAR CELL; NORMAL HUMAN; OBSERVATIONAL STUDY; PERIPHERAL BLOOD STEM CELL; PREDICTIVE VALUE; PROSPECTIVE STUDY; STEM CELL MOBILIZATION; THROMBOCYTE COUNT; DONOR; METABOLISM; MIDDLE AGED; PROCEDURES;

ADULT; ANTIGENS, CD34; COHORT STUDIES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; IMMUNOPHENOTYPING; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TISSUE DONORS;

EID: 85018160864     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2017.03.024     Document Type: Article

References (40)

1. Ljungman, P., Bregni, M., Brune, M., et al., European Group for Blood and Marrow. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant 45 (2010), 219–234.
2. Niederwieser, D., Baldomero, H., Szer, J., et al. Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey. Bone Marrow Transplant 51 (2016), 778–785.
3. Passweg, J.R., Baldomero, H., Bader, P., et al. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplant 51 (2016), 786–792.
4. Machaczka, M., Kalaitzakis, E., Eleborg, L., et al. Comparison of general vs regional anaesthesia for BM harvesting: a retrospective study of anaesthesia-related complications. Bone Marrow Transplant 45 (2010), 53–61.
5. Bensinger, W.I., Allogeneic transplantation: peripheral blood versus bone marrow. Curr Opin Oncol 24 (2012), 191–196.
6. Passweg, J.R., Baldomero, H., Peters, C., et al. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation. Bone Marrow Transplant 49 (2014), 744–750.
7. Martino, M., Fedele, R., Massara, E., et al. Long-term safety of granulocyte colony- stimulating factor in normal donors: is it all clear?. Expert Opin Biol Ther 12 (2012), 609–621.
8. Schmitz, N., Eapen, M., Horowitz, M.M., et al. Long-term outcome of patients given transplants of mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood 108 (2006), 4288–4290.
9. Duong, H.K., Savani, B.N., Copelan, E., et al. Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 20 (2014), 1262–1273.
10. Pierelli, L., Perseghin, P., Marchetti, M., et al. Best practice for peripheral blood progenitor cell mobilization and collection in adults and children: results of a Società Italiana Di Emaferesi e Manipolazione Cellulare (SIDEM) and Gruppo Italiano Trapianto Midollo Osseo (GITMO) consensus process. Transfusion 52 (2012), 893–905.
11. Stroncek, D.F., Clay, M.E., Petzoldt, M.L., et al. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 36 (1996), 601–610.
12. Korbling, M., Anderlini, P., Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?. Blood 98 (2001), 2900–2908.
13. Martino, M., Morabito, F., Callea, I., et al. Harvesting peripheral blood progenitor cells from healthy donors with a short course of recombinant human granulocyte-colony-stimulating factor. Transfus Med 15 (2005), 323–328.
14. Vasu, S., Leitman, S.F., Tisdale, J.F., et al. Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood 112 (2008), 2092–2100.
15. Wang, T.F., Wen, S.H., Chen, R.L., et al. Factors associated with peripheral blood stem cell yield in volunteer donors mobilized with granulocyte colony-stimulating factors: the impact of donor characteristics and procedural settings. Biol Blood Marrow Transplant 14 (2008), 1305–1311.
16. Rinaldi, C., Savignano, C., Pasca, S., et al. Efficacy and safety of peripheral blood stem cell mobilization and collection: a single center experience in 190 allogeneic donors. Transfusion 52 (2012), 2387–2394.
17. Martino, M., Callea, I., Condemi, A., et al. Predictive factors that affect the mobilization of CD34(+) cells in healthy donors treated with recombinant granulocyte colony stimulating factor (G-CSF). J Clin Apher 21 (2006), 169–175.
18. de la Rubia, J., Arbona, C., de Arriba, F., et al. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion 42 (2002), 4–9.
19. Bertani, G., Santoleri, L., Martino, M., et al. Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter study. Transfusion 54 (2014), 2028–2033.
20. Martino, M., Bonizzoni, E., Moscato, T., et al. Mobilization of hematopoietic stem cells with lenograstim in healthy donors: efficacy and safety analysis according to donor age. Biol Blood Marrow Transplant 21 (2015), 881–888.
21. Grigg, A.P., Roberts, A.W., Raunow, H., et al. Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 86 (1995), 4437–4445.
22. Ings, S.J., Balsa, C., Leverett, D., et al. Peripheral blood stem cell yield in 400 normal donors mobilized with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used. Br J Haematol 134 (2006), 517–525.
23. Martino, M., Console, G., Irrera, G., et al. Harvesting peripheral blood progenitor cells from healthy donors: retrospective comparison of filgrastim and lenograstim. J Clin Apher 20 (2005), 129–136.
24. Martino, M., Moscato, T., Barillà, S., et al. Mobilization of hematopoietic progenitor stem cells in allogeneic setting with lenograstim by subcutaneous injection, in daily or twice-daily dosing: a single-center prospective study with historical control. Transfusion 55 (2015), 2032–2038.
25. Brown, R.A., Adkins, D., Goodnough, L.T., et al. Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies. J Clin Oncol 15 (1997), 3067–3074.
26. de la Rubia, J., Lorenzo, J.I., Torrabadella, M., Marín, P., Insunza, A., Sanz, M.A., Basal CD34(+) cell count predicts peripheral blood progenitor cell mobilization and collection in healthy donors after administration of granulocyte colony-stimulating factor. Haematologica 89 (2004), 1530–1532.
27. Nadler, S.B., Hidalgo, J.H., Bloch, T., Prediction of blood volume in normal human adults. Surgery 51 (1962), 224–232.
28. Brando, B., Barnett, D., Janossy, G., et al. Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. Cytometry 42 (2000), 327–346.
29. Herbert, D.J., Miller, D.T., Bruce Bagwell, C., Automated analysis of flow cytometric data for CD34+ stem cell enumeration using a probability state model. Cytometry B Clin Cytom 82 (2012), 313–318.
30. Keeney, M., Brown, W., Gratama, J., et al. Single platform enumeration of viable CD34 pos cells. J Biol Regul Homeost Agents 17 (2003), 247–253.
31. Yüksel, M.K., Tekgündüz, E., Sönmez, C., et al. A feasible shortcut for the mobilization outcome: steady state CD34 positive hematopoietic stem cells. Transfus Apher Sci 47 (2012), 67–75.
32. Bogunia-Kubik, K., Suchnicki, K., Lange, A., HLA–DR11 in addition to donor age, gender, and major blood group incompatibility influence the incidence of acute graft versus- host disease after allogeneic hematopoietic stem cell transplantation. Transplant Proc 35 (2003), 1556–1558.
33. Atkinson, K., Farrell, C., Chapman, G., et al. Female marrow donors increase the risk of acute graft-versus-host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum. Br J Haematol 63 (1986), 231–239.
34. Osarogiagbon, R.U., Defor, T.E., Weisdorf, M.A., et al. CMV antigenemia following bone marrow transplantation: risk factors and outcomes. Biol Blood Marrow Transplant 6 (2000), 280–288.
35. Confer, D.L., Unrelated marrow donor registries. Curr Opin Hematol 4 (1997), 408–412.
36. Koh, L.P., Chao, N., Haploidentical hematopoietic cell transplantation. Bone Marrow Transplant 42:suppl 1 (2008), S60–S63.
37. Devine, S.M., Flomenberg, N., Vesole, D.H., et al. Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma. J Clin Oncol 22 (2004), 1095–1102.
38. Gattillo, S., Marktel, S., Rizzo, L., et al. Plerixafor on demand in ten healthy family donors as a rescue strategy to achieve an adequate graft for stem cell transplantation. Transfusion 55 (2015), 1993–2000.
39. Lanza, F., Gardellini, A., Laszlo, D., Martino, M., Plerixafor: what we still have to learn. Expert Opin Biol Ther 15 (2015), 143–147.
40. Eidenschink, L., Di Zerega, G., Rodgers, K., Bartlett, M., Wells, D.A., Loken, M.R., Basal levels of CD34 positive cells in peripheral blood differ between individuals and are stable for 18 months. Cytometry B Clin Cytom 82 (2012), 18–25.